Bowlus, C. L., Patel, K., Guha, I. N., Chapman, R. W., Chazouilleres, O., Chalasani, N. P., … Levy, C. (2015). Validation of serum fibrosis marker panels in patients with primary sclerosing cholangitis (PSC) in a randomized trial of simtuzumab. In HEPATOLOGY (Vol. 62, pp. 519A-519A). San Francisco, CA: WILEY-BLACKWELL.

Bowlus, Christopher L., Keyur Patel, Indra Neil Guha, Roger W. Chapman, Olivier Chazouilleres, Naga P. Chalasani, John M. Vierling, et al. “Validation of serum fibrosis marker panels in patients with primary sclerosing cholangitis (PSC) in a randomized trial of simtuzumab.” In HEPATOLOGY, 62:519A-519A. WILEY-BLACKWELL, 2015.

Bowlus CL, Patel K, Guha IN, Chapman RW, Chazouilleres O, Chalasani NP, et al. Validation of serum fibrosis marker panels in patients with primary sclerosing cholangitis (PSC) in a randomized trial of simtuzumab. In: HEPATOLOGY. WILEY-BLACKWELL; 2015. p. 519A-519A.

Bowlus, Christopher L., et al. “Validation of serum fibrosis marker panels in patients with primary sclerosing cholangitis (PSC) in a randomized trial of simtuzumab.” HEPATOLOGY, vol. 62, WILEY-BLACKWELL, 2015, pp. 519A-519A.

Bowlus CL, Patel K, Guha IN, Chapman RW, Chazouilleres O, Chalasani NP, Vierling JM, Myers RP, Ding D, Schall REA, Subramanian M, McHutchison JG, Muir AJ, Goodman ZD, Levy C. Validation of serum fibrosis marker panels in patients with primary sclerosing cholangitis (PSC) in a randomized trial of simtuzumab. HEPATOLOGY. WILEY-BLACKWELL; 2015. p. 519A-519A.